CREB1 and non-small cell lung carcinoma: Our data from in vitro and in vivo experiments revealed that MHY4571 functions as a novel PKA inhibitor in NSCLC and exerts anticancer effects mediated by the inactivation of the PKA-CREB signaling pathway.